Session Details

[O]Parvoviridae / Papilomaviridae / Polyomaviridae

Mon. Nov 2, 2026 2:55 PM - 4:07 PM JST
Mon. Nov 2, 2026 5:55 AM - 7:07 AM UTC
Room 5 (3F Room 303)
Chair: Eiji Morita (Department of Biochemistry and Molecular Biology, Faculty of Agriculture and Life Science, Hirosaki University)
   Seiichiro Mori (Pathogen Genomics Center, National Institute of Infectious Diseases, Japan Institute for Health Security (JIHS))

[O1-5-10]Genetic characterization of a novel papillomavirus, AalbPV2, detected in four-toed hedgehog

*Yota Konagai1, Chiaki Kita2, James K Chambers3, Kei Nabeshima4, Masato Nikaido5, Yukinobu Tohya1, Ryota Koba1, Tohru Suzuki1 (1. Laboratory of Veterinary Microbiology, College of bioresource sciences, Nihon University, 2. Shikoku Cytopathological Laboratory, 3. Laboratory of Veterinary Pathology, The University of Tokyo, 4. Biodiversity Division, National Institute for Environmental Studies, 5. School of Life Science and Technology, Institute of Tokyo science)

[O1-5-11]Vaccine adjuvant monophosphoryl lipid A (MPL) induces cross-reactive anti-lipid A antibodies

*Sandesh Rimal1, Reona Shiro2,1, Fumitaka Sato1, Ijaz Ahmed3,1, Ah-Mee Park4, Cong Thanh Nguyen1, Alfredo A Hinay Jr1, Koichi Fukase5, Atsushi Shimoyama5, Ikuo Tsunoda1 (1. Kindai University Faculty of Medicine, Department of Microbiology, Osaka, Japan, 2. University of New Mexico School of Medicine, Department of Molecular Genetics & Microbiology, New Mexico, USA, 3. Nagasaki University, Department of Tropical Viral Vaccine Development, Institute of Tropical Medicine, Nagasaki, Japan, 4. Kindai University Faculty of Medicine, Department of Arts and Science, Osaka, Japan, 5. The University of Osaka,Department of Chemistry, Osaka, Japan)

[O1-5-12]Infection and replication of JC polyomavirus in human iPS cell-derived brain organoids and neurons

*Ryoko Enomoto1, Zhiping Chen1, Yoomin Park2, Gwanghyun Park2, Jeyoung Ryu2, Yoh-ichi Tagawa1 (1. Institute of Science Tokyo, School of Life Science and Technology, 2. Gradiant Bioconvergence Inc.)

[O1-5-13]Human Parvovirus B19 Small 11-kDa Protein Competitively Disrupts Grb2–SOS Interaction by to the N-Terminal SH3 Domain of Grb2

*Masashi Arakawa1, Sakika Kimura1, Keiya Uriu1, Toshitsugu Fujita2, Hodaka Fujii2, Hirotaka Ebina3, Eiji Morita1 (1. Department of Biochemistry and Molecular Biology,Hirosaki University, 2. Department of Biochemistry and Genome Biology, Hirosaki University Graduate School of Medicine, 3. The Research Foundation for Microbial Diseases of Osaka University)

[O1-5-14]Identification of novel avian chaphamaparvoviruses and associated host gene expression changes using publicly available RNA-seq data

*Hana Sasaki1, Mai Kishimoto1,2, Masayuki Horie1,2 (1. School of Veterinary Science, College of Life, Environment, and Advanced Science, Osaka Prefecture University, 2. Osaka International Research Center for Infectious Diseases)

[O1-5-15]Development and Evaluation of a Human Parvovirus B19 Infection Model Using Humanized Mice

*Kengo Takeda1,2, Takahumi Noguchi1,2, Kaoru Yamano1,2, Paola Miyazato1,2, Shinya Okamura1,2, Eiji Morita3, Hirotaka Ebina1,2 (1. Virus Vaccine Group, BIKEN Innovative Vaccine Research Alliance Laboratories, Institute for Open and Transdisciplinary Research Initiatives, The University of Osaka, 2. The Research Foundation for Microbial Diseases of Osaka University, 3. Department of Biochemistry and Molecular Biology, Faculty of Agriculture and Life Science, Hirosaki University)